Need help?

Businesses for Sale and Investment

Showing 1 - 14 of 21,459 Businesses for Sale and Investment. Buy or Invest in a Business. Listed by Direct Business Owners & Business Brokers.
Filters
 

Newly Established Alternative Medicine Company Seeking Loan in Aveiro, Portugal

Pre-revenue cannabis farm seeks loan to build infrastructure for GACP/GMP-compliant premium cannabis production.
Based in Aveiro, the company will specialise in GACP and GMP-compliant medicinal cannabis, catering to Europe's growing demand in the alternative medicine sector. - Having conducted R&D for over 4 years, the company is strategically positioned with INFARMED-approved licenses for import, export, and production of medicinal cannabis. - Situated on 2.4 hectares of land ready for infrastructure development, aiming to secure EUR 2 million to expedite project completion. - The company already has well-established client relationships and strategic partnerships, ensuring a fully integrated supply chain from cultivation to the sale of dried cannabis flowers to pharmaceutical clients. - The business holds no current loan obligations, relying instead on partner contributions for initial costs, highlighting a financially prudent approach. - Market trends indicate a rising global demand for medicinal cannabis, aligning with the company's operations and future growth potential. - Full operational readiness is projected within 12 months following the investment, promising swift returns for prospective investors. - Has an experienced internal and external team poised to commence operations upon receiving the necessary funding.
5.6   Aveiro
Run Rate Sales
Nil
EBITDA Margin
Nil
Business Loan
USD 2.24 Mn at 10%
Contact Business

Alternative Medicine Company Seeking Loan in Coimbra, Portugal

European medical cannabis producer and distributor with a license for production, sales, and export.
European company that grows and sells medical cannabis in Europe and to other countries. - We grow medical cannabis in-house in a controlled environment and distribute them to clients. - Growing 74 varieties of medical cannabis in all ranges of THC and CBD. Good opportunity for CBD products, since Europe considers it as a controlled substance. - We used to grow strawberries before and our products were considered the best strawberries in the world that used to sell at EUR 17 per kg. - We stopped growing strawberries and shifted to medical cannabis due to a family member's health reasons. - Business owner and management members have a strong knowledge of agriculture, medicine, Olímpic Sport level medicine, and pharmaceuticals. - Have a stronger demand than before due to Covid-19. - Have 2 running contracts with medical companies and expect 5-6 new contracts in 1-2 months. - Each contract is valid for 2-3 years and could be renewed. - We currently grow 200-300 kgs of medical cannabis and planning to increase the production due to more demand. - Majority of the clients are from Germany and the Netherlands. - Also working with 20 distributors who are allowed to buy and sell medical cannabis. - Have the best equipment and machinery required for the job and the facility including a cloning room, drying room, security facility, and water tanks.
European medical cannabis producer and distributor with a license for production, sales, and export.
7.9   Coimbra
Run Rate Sales
USD 2.8 million
EBITDA Margin
22 %
Business Loan
USD 2.24 Mn at 8%
Contact Business

Biotechnology Business for Sale in Alcobaça, Portugal

Highly profitable and certified food innovation business group with multiple brands, spin-offs and government grants.
Privately owned food technology company, certified by the Portuguese innovation agency (SIFIDE). - Highly profitable, low fixed costs, perfect for investment. - The leading company of the group owns several brands and multiple spin-offs and is a European leader in plant-based, fermentation and sports nutrition development, with abundant press coverage. The company offers private label opportunities to clients. - No debt or loans, very well managed over the last 5 years, with more than 200% growth and permanent profit. - The leading company provides R&D services to companies and public entities and is very well connected in the R&D grants and funding business, with more than €2M submitted in grants for the next two years. - More than 15 revenue streams between R&D services, third-party manufacturing clients, public grants and innovation tenders. - Planning on verticalizing the business with the construction of a supplements laboratory and a drinks manufacturing operation in 2024, which will be financed by the state in more than 50%. - The company pays practically zero tax on profits as it is a research activity. - Its dynamics and flexibility allow to creation of products and companies in any food or supplement area. - There are 6 permanent employees and 1 part-time designer.
7.8   Alcobaça
Run Rate Sales
USD 710 thousand
EBITDA Margin
25 %
Business for Sale
USD 2.54 Mn
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Biotechnology Business for Sale in Alcobaça, Portugal

Highly profitable and certified food innovation business group with multiple brands, spin-offs and government grants.
Privately owned food technology company, certified by the Portuguese innovation agency (SIFIDE). - Highly profitable, low fixed costs, perfect for investment. - The leading company of the group owns several brands and multiple spin-offs and is a European leader in plant-based, fermentation and sports nutrition development, with abundant press coverage. The company offers private label opportunities to clients. - No debt or loans, very well managed over the last 5 years, with more than 200% growth and permanent profit. - The leading company provides R&D services to companies and public entities and is very well connected in the R&D grants and funding business, with more than €2M submitted in grants for the next two years. - More than 15 revenue streams between R&D services, third-party manufacturing clients, public grants and innovation tenders. - Planning on verticalizing the business with the construction of a supplements laboratory and a drinks manufacturing operation in 2024, which will be financed by the state in more than 50%. - The company pays practically zero tax on profits as it is a research activity. - Its dynamics and flexibility allow to creation of products and companies in any food or supplement area. - There are 6 permanent employees and 1 part-time designer.
7.8   Alcobaça
Run Rate Sales
USD 710 thousand
EBITDA Margin
25 %
Business for Sale
USD 2.54 Mn
Contact Business

Alternative Medicine Company for Sale in Lisbon, Portugal

For Sale: Portugal based company involved in cultivating medical cannabis.
Business is involved in the agricultural industry. - We produce medical cannabis. - Business produces this cannabis on their own land. - We own a licence for production. - Business was awarded as the most potent autoflower in the world for 28% THC. - We are the highest CBD and THC, cultivators. - Business has a specific variety with up to 20% CBD with CoA. - Company is ready to start operating but due to a lack of funds for marketing and operation, the owner wants to sell the business. - Business has ample potential and opportunity to make profit. - The selling price includes the stocks that we have. - Business is open to get investors as well. - We have attached our pitch deck which we want to present to our buyers/investors.
For Sale: Portugal based company involved in cultivating medical cannabis.
8.4   Lisbon
Run Rate Sales
Nil
EBITDA Margin
Nil
Business for Sale
USD 11.2 Mn
Contact Business

Newly Established Alternative Medicine Company Investment Opportunity in Milan, Italy

Invest in a non-operational Italian GMP EU facility planning THC, CBD-API production for pharmacies.
Located in Milan, the business will operate a GMP EU-certified facility specializing in therapeutic cannabis production. - The company will supply Italian pharmacies with high-quality THC and CBD Active Pharmaceutical Ingredients (API), serving a burgeoning market demand. - Two primary product lines will focus on CBD solutions, catering to both human and animal health sectors and expanding market reach across multiple demographics. - Strong market interest is evidenced by over 100 Italian pharmacies already expressing interest in purchasing CBD and THC products directly from the business. - Recognized for excellence, the company has received an agriculture award, highlighting its innovative cannabis cultivation methods and establishing it as a leader in Italian agriculture. - Positioned within the alternative medicine industry, the business capitalizes on the growing trend towards natural and plant-based therapeutic options in Europe.
6.9   Milan
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 3.36 Mn for 49%
Contact Business

Newly Established Alternative Medicine Company Investment Opportunity in Hamburg, Germany

Concept of providing rental services to cannabis clubs in Germany. High EBITDA, fast ROI.
GWS designs, builds and rents cannabis growing facilities in Germany. Experts with legal recreational and medicinal cannabis cultivation in the Netherlands. We are committed to working with at least 20 cannabis clubs in Germany. We have the potential to service 10% of the cannabis club market in Germany. Expected EBITDA in the next 7 years will be EUR 27 M. When we are operating 20 facilities. We have built 2 cannabis growing facilities for now and planning to build 18 more soon. Once the facility is developed, we rent it to a tenant who will run the business and pay us a monthly rent. This is how we generate revenue. Revenue is based on rental agreements with legal cannabis clubs. Have a cannabis license, and building permits in place. Business is registered in Amsterdam but most of the operations are in Germany. All our branches are located in Germany. Promoter is the Netherlands and runs the operations from there. We hire staff on a project basis and have 3 permanent employees.
Concept of providing rental services to cannabis clubs in Germany. High EBITDA, fast ROI.
8   Hamburg
Run Rate Sales
USD 8 million
EBITDA Margin
40 %
Partial Stake Sale
USD 2.24 Mn for 20%
Contact Business

Nutraceuticals Company Investment Opportunity in Srebrenik, Bosnia

Nutraceuticals company, based in Bosnia with > €6 million annual revenue, 45,000 orders to date.
Nutraceutical manufacturing, tech marketing & sales company, based in Srebrenik, Bosnia. - Our products are nutraceutical supplements for common disease conditions such as, prostate, hemorrhoids, diabetes and hypertension weight loss and hair loss. - Planning to launch products for more disease conditions such as psoriasis and other skin conditions. - Our clients are individual customers from countries across Eastern Europe such as Serbia, Croatia, Romania etc. Planning to expand to other European countries as well. - We get about 3 to 4k orders every month. Average value of each product is EUR 75. - Manufacturing capacity is 70k products everyday. - Since its inception, the company has showcased significant financial growth, with revenues escalating from €700,000 in 2021 to €5 million last year, and anticipated revenue of around €6 to €7 million for this year. - Till date, we’ve successfully crossed over 45,000 orders, evidencing strong market engagement. - Our seasoned leadership team has been instrumental in nurturing valuable industry relationships. - Our innovative in-house SaaS projects have bolstered our operational prowess: our affiliate network; an ads tracking software; a call center software enhancing our sales processes and a website builder facilitating seamless online presence. - There are 98 permanent employees. Additionally, we have 200+ contract marketing partners. - The company has ISO, GMP, and MoH licenses.
Nutraceuticals company, based in Bosnia with > €6 million annual revenue, 45,000 orders to date.
7.4   Srebrenik
Run Rate Sales
USD 6.7 million
EBITDA Margin
13 %
Partial Stake Sale
USD 5.6 Mn for 20%
Contact Business

Profitable Nutraceuticals Company Investment Opportunity in London, UK

First-to-market D2C B2B nutraceutical ingredient and supplement company seeks investment for expansion.
Gold-standard research has established our product as an elite, unique breakthrough branded ingredient and finished goods that have been commercially tested and proven in the Australasian, US and UK marketplace. As a supplier to English Premier League football clubs, and high-performance sports organizations such as the US Military, our product is used in the services and elite sports to provide a proven, legal competitive advantage. We have an official New Zealand All Blacks, product and collaborate with sports supplement companies such as Healthspan Elite and Science in Sport. Aside from finished goods, we have the branded ingredient, backed by a volume of clinicals, making a high-growth potential product in the US and EU. With restrictions on health claims in the EU, our finished goods marketing strategy is focused on the US, where we entered the market in 2022 and seeing strong growth in our D2C channels. Our unique provenance story centers around NZ’s powerful climate, which produces an exceptional polyphenol-rich berry fruit unique to the region. With concentrations and combinations of bioactive not present in any other berry, our fruit is key to producing a high-quality, high-potency extract that delivers a host of antioxidant, vasodilatory, and anti-inflammatory actions. The product’s exceptional multiplicity of physiological properties has led to international brand recognition, with five Sports Nutrition Product Champion awards (Nutra Ingredients/ESSNA - Europe, USA, Asia), and three Best Recovery Product titles (UK, Europe). We have been shortlisted once again for the Champion Sports Nutrition Award in Europe this year. With our product name-checked in all published studies, our material and science are responsible for many of the major anthocyanin-derived breakthroughs of the last decade. Our current combined revenues are operating at approx USD 700,000 from our small business enterprises in the UK, NZ, and Australia. As the first-to-market New Zealand blackcurrant brand, the company’s primary focus is to capitalize on a decade of research investment and development. A well-supported sales and marketing strategy can leverage this rare offering with the right strategic partner.
First-to-market D2C B2B nutraceutical ingredient and supplement company seeks investment for expansion.
8.4   London
Run Rate Sales
USD 880 thousand
EBITDA Margin
40 %
Partial Stake Sale
USD 4 Mn for 50%
Contact Business

Generic Pharmaceuticals Company Seeking Loan in Cuttack, India

Pharmaceutical company marketing in Odisha having more than 30 registered brands.
We are a pharmaceutical company based in Odisha that develops quality healthcare products of ortho, O&G and GP range. These products are used as painkillers, heart problem-related medications and vitamin supplements to name a few. Products are developed and branded under our name, but we outsource the manufacturing process of these medicines as of now. We have more than 400 Doctors who are prescribing our brands across Odisha and plan to expand to other region and start our own manufacturing unit. Our products are sold through a channel, we sell the products to a distributor and it goes to retailers and then it goes to customers. In some cases, doctors purchase our products directly. Company is growing by 20-25% every year in terms of business.
7.8   Cuttack
Run Rate Sales
USD 280 thousand
EBITDA Margin
20 - 30 %
Business Loan
USD 88 K at 18%
Contact Business

Bio Diagnostics Company Investment Opportunity in Uxbridge, UK

Invest in the UK healthcare business for potential growth in the gene therapy field.
• Healthcare business located in the United Kingdom offering gene therapy products and services. • University spin-out with patented technology and other scientific developments in the pipeline. • Aiming to improve the safety and efficiency of gene therapy. • Top selling products will be tests to ascertain if a person can repair their DNA, testing if a virus used to deliver a gene therapy will actually be safe. • Gene therapy and CAR-T therapy is a rapidly growing field, offering great potential for the company. • Experienced team of scientists and engineers ready to create a successful business. The business is not operational currently. • Unique products and services that can be marketed to potential customers worldwide.
8.4   Uxbridge
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 650 K for 25%
Contact Business

Alternative Medicine Company Investment Opportunity in Tirana, Albania

Start up essential oil company with a manufacturing capacity of 200 liters monthly.
Albanian-based essential oil distillery that specializes in the production of high-quality, organic essential oils using native plants found in the Albanian flora. - We are committed to preserving and promoting the rich botanical heritage of Albania by sustainably sourcing our raw materials and using traditional distillation methods to extract the purest essential oils. - Our team of experts is dedicated to ensuring that our oils are of the highest quality and potency, and we are proud to offer a wide range of natural and pure essential oils that are perfect for use in aromatherapy, personal care, and wellness products. - The production capacity of the unit is 200 liters monthly. - As a supplier we are committed to offering competitive prices and building long-lasting relationships with our customers by providing exceptional service and quality. - We are looking to start the production once we get the investment.
6.2   Tirana
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 560 K for 20%
Contact Business

Biotechnology Company Investment Opportunity in Brussels, Belgium

AI-enhanced physics-based drug discovery company with diverse clientele, seeking investment for R&D activities in pipeline.
An AI-enhanced physics-based drug discovery company. - Integrates artificial intelligence, computational chemistry, and peptide science to expedite therapeutic compound discovery and optimize leads. - Discovers and optimizes active, specific, non-toxic, and patentable small molecules delivering superior drug candidates. - The company boasts a diverse clientele, with more than 6 clients including reputable organizations such as Deloitte Belgium, B. Braun, Fresenius Kabi, and UCB Pharma. - The company currently generates revenue through the provision of management consulting services for pharmaceutical and biotech companies. It operates on a per-service-based charging model. - Company is currently engaged in the development of brain-specific and selective butyrylcholinesterase inhibitors for the treatment of severe Alzheimer's. - The business is not yet profitable as it is reinvesting its revenue into research and development activities, - The company has 2 additional contract employees for R&D activities.
6.6   Brussels
Run Rate Sales
USD 134 thousand
EBITDA Margin
Nil
Partial Stake Sale
USD 560 K for 25%
Contact Business

Ecommerce Website Investment Opportunity in Paris, France

E-commerce website dealing with natural food supplements seeks financial investment.
We are an online marketplace and 100% of our sales are through our website. - On a daily basis we receive 5-10 orders. - As of now we have in-house shipping and are seeking investment to expand the same and brand building. - We have tie-ups with direct manufacturers from whom we source our products. - The business has not taken any loan previously. - The company has two partners but the entire ownership is with one promoter.
6.2   Paris
Run Rate Sales
USD 54 thousand
EBITDA Margin
20 - 30 %
Partial Stake Sale
USD 224 K for 20%
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Milan, Italy

Biotech firm focused on cancer immuno personalized therapy and exosomes for medical and cosmetic applications.
A biotech firm based in Milan, focusing on cancer immuno personalized therapy. - Has a portfolio of R&D projects and two Finished Dosage Forms (FDF) in the Italian market, including Aripiprazole and Emtricitabine + Tenofovir. - The company specializes in the development of microfluidic technology for the production and purification of Exosomes, with applications in anti-inflammatory, skin regenerative, anti-acne and atopic dermatitis, scalp rejuvenation, and hair growth treatments. - Exosomes, a key product of the company, are body-identical ingredients known for their high stability and low likelihood of causing adverse reactions. Their cell-penetrating mechanism enables them to deliver regeneration signals, making them suitable for diverse medical and cosmetic applications. - Has 3 major clients and supplied on a quarterly basis to pharmaceutical companies in Italy, Poland, and Brazil. - Operates with a network of 12 agents in addition to its 3 permanent employees. - Collaborates with Contract Manufacturing Organizations (CMOs) for the production of its pharmaceutical products. The company holds essential regulatory licenses from GMP, FDA, and the Ministry of Health, ensuring compliance with international quality and safety standards.
7.1   Milan
Run Rate Sales
USD 336 thousand
EBITDA Margin
35 %
Partial Stake Sale
USD 1.68 Mn for 25%
Contact Business

Investing in Businesses: A Comprehensive Guide

Investing in businesses is a strategic endeavor that can significantly grow your wealth if approached knowledgeably. Whether you're a seasoned investor or just starting, understanding the intricacies of businesses for investment is crucial.

Understanding Business Investment

Business investment refers to the allocation of capital to a company with the expectation of receiving financial returns. This can occur through direct investment in a private company or by purchasing stocks and shares of publicly traded businesses.

Types of Business Investments

  1. Equity Investment: This involves purchasing shares of a company. Equity investors become partial owners and have potential returns through dividends and appreciation of the stock value.

  2. Debt Investment: Investors lend money to businesses in exchange for interest income. This can include corporate bonds or business loans.

  3. Venture Capital and Angel Investing: These are types of equity investment where investors provide capital to startups and small businesses that have potential for growth.

  4. Crowdfunding: An innovative way to invest in businesses where multiple investors contribute small amounts of capital via platforms like Kickstarter or Indiegogo.

Advantages of Investing in Businesses

  • Potential for High Returns: Businesses have the potential to grow substantially, resulting in significant returns on investment.
  • Portfolio Diversification: Investing in various businesses can diversify an investment portfolio, reducing overall risk.
  • Active Involvement: Investors can actively participate in their investments, offering guidance and support to businesses.

Risks Involved in Business Investment

Even though investing in businesses offers attractive returns, it involves certain risks:

  • Market Volatility: Economic changes can affect business profitability and stock prices.
  • Failure Risk: Especially with startups, there's always a risk of failure resulting in loss of investment.
  • Regulatory Issues: Changes in laws and regulations can impact businesses adversely.

How to Choose the Right Business for Investment

  • Research and Analysis: Understand the business model, industry sector, and financial health of the business.
  • Growth Potential: Evaluate the business's potential for growth and scalability.
  • Management Quality: A competent management team can greatly influence a business’s success.
  • Market Trends: Stay updated with market trends and economic conditions that might affect the business.
  • Competitive Advantage: Ensure the business has a unique selling proposition or competitive edge.

Conclusion

Investing in businesses for investment can be incredibly rewarding. However, it requires a thorough understanding of the market, diligent research, and careful selection. By weighing the potential benefits against the risks and conducting due diligence, investors can enhance their ability to make profitable investments. Always consider consulting a financial advisor to tailor your investment strategy to your personal financial goals and risk tolerance.

Invest wisely, and watch your investments flourish!

Frequently
Asked
Questions
  • How many businesses for sale and investment are listed on SMERGERS?
    There are 21459 active and verified businesses for sale and investment listed on SMERGERS as of 18 May 2025.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more